Literature DB >> 29685931

miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease.

Zhan-Peng Huang1,2, Da-Zhi Wang2.   

Abstract

Entities:  

Keywords:  Editorials; cardiovascular disease; gene regulation; gene therapy; microRNA; non-coding RNA; smooth muscle; vascular smooth muscle

Mesh：

Substances：

Year:  2018        PMID： 29685931      PMCID： PMC5918419          DOI： 10.1161/CIRCULATIONAHA.118.033042

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.

Authors:  Sebastian Albinsson; Yajaira Suarez; Athanasia Skoura; Stefan Offermanns; Joseph M Miano; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-08       Impact factor: 8.311

2.  Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects.

Authors:  Zhan-Peng Huang; Jian-Fu Chen; Jenna N Regan; Colin T Maguire; Ru-Hang Tang; Xiu Rong Dong; Mark W Majesky; Da-Zhi Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-30       Impact factor: 8.311

3.  MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts.

Authors:  Yuan Hong; Huaming Cao; Qiang Wang; Jianlin Ye; Lijun Sui; Jinhua Feng; Xiaojun Cai; Huizhu Song; Xiuhong Zhang; Xichuang Chen
Journal:  Cell Physiol Biochem       Date:  2016-12-19

4.  Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.

Authors:  Shashi Kumar Gupta; Ariana Foinquinos; Sabrina Thum; Janet Remke; Karina Zimmer; Christophe Bauters; Pascal de Groote; Reinier A Boon; Leon J de Windt; Sebastian Preissl; Lutz Hein; Sandor Batkai; Florence Pinet; Thomas Thum
Journal:  J Am Coll Cardiol       Date:  2016-10-04       Impact factor: 24.094

5.  Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction.

Authors:  Priyatansh Gurha; Cei Abreu-Goodger; Tiannan Wang; Maricela O Ramirez; Ana L Drumond; Stijn van Dongen; Yuqing Chen; Nenad Bartonicek; Anton J Enright; Brendan Lee; Robert J Kelm; Anilkumar K Reddy; George E Taffet; Allan Bradley; Xander H Wehrens; Mark L Entman; Antony Rodriguez
Journal:  Circulation       Date:  2012-05-08       Impact factor: 29.690

6.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.

Authors:  Jian-Fu Chen; Elizabeth P Murchison; Ruhang Tang; Thomas E Callis; Mariko Tatsuguchi; Zhongliang Deng; Mauricio Rojas; Scott M Hammond; Michael D Schneider; Craig H Selzman; Gerhard Meissner; Cam Patterson; Gregory J Hannon; Da-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-06       Impact factor: 11.205

7.  miR-22 represses cancer progression by inducing cellular senescence.

Authors:  Dan Xu; Fumitaka Takeshita; Yumiko Hino; Saori Fukunaga; Yasusei Kudo; Aya Tamaki; Junko Matsunaga; Ryou-U Takahashi; Takashi Takata; Akira Shimamoto; Takahiro Ochiya; Hidetoshi Tahara
Journal:  J Cell Biol       Date:  2011-04-18       Impact factor: 10.539

8.  Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function.

Authors:  Sebastian Albinsson; Athanasia Skoura; Jun Yu; Annarita DiLorenzo; Carlos Fernández-Hernando; Stefan Offermanns; Joseph M Miano; William C Sessa
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

Review 9.  Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).

Authors:  Jingyu Wang; Yuan Li; Meiman Ding; Honghe Zhang; Xiaoming Xu; Jinlong Tang
Journal:  Int J Oncol       Date:  2016-12-19       Impact factor: 5.650

10.  miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.

Authors:  Feng Yang; Qishan Chen; Shiping He; Mei Yang; Eithne Margaret Maguire; Weiwei An; Tayyab Adeel Afzal; Le Anh Luong; Li Zhang; Qingzhong Xiao
Journal:  Circulation       Date:  2017-12-15       Impact factor: 29.690
View more
  5 in total

Review 1.  The role of cellular senescence in cardiac disease: basic biology and clinical relevance.

Authors:  Mozhdeh Mehdizadeh; Martin Aguilar; Eric Thorin; Gerardo Ferbeyre; Stanley Nattel
Journal:  Nat Rev Cardiol       Date:  2021-10-19       Impact factor: 32.419

Review 2.  Gene therapy for cardiovascular diseases in China: basic research.

Authors:  Jiali Deng; Mengying Guo; Guoping Li; Junjie Xiao
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

Review 3.  Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis.

Authors:  Fahimeh Varzideh; Urna Kansakar; Kwame Donkor; Scott Wilson; Stanislovas S Jankauskas; Pasquale Mone; Xujun Wang; Angela Lombardi; Gaetano Santulli
Journal:  Front Cardiovasc Med       Date:  2022-04-13

4.  MiR-22 as a metabolic silencer and liver tumor suppressor.

Authors:  Lijun Wang; Yu-Shiuan Wang; Eko Mugiyanto; Wei-Chiao Chang; Yu-Jui Yvonne Wan
Journal:  Liver Res       Date:  2020-06-09

5.  LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22/NLRP3 axis in hyperuricaemia.

Authors:  Kun Chi; Xiaodong Geng; Chao Liu; Yang Zhang; Jie Cui; GuangYan Cai; Xiangmei Chen; Fangfang Wang; Quan Hong
Journal:  J Cell Mol Med       Date:  2021-07-22       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.